Editorial
doi: 10.1097/GME.0000000000002250.
Epub 2023 Sep 12.
Will long term use of hormone therapy fade away?
Affiliations
- PMID: 37699244
- DOI: 10.1097/GME.0000000000002250
Item in Clipboard
Editorial
Will long term use of hormone therapy fade away?
Menopause.
.
No abstract available
Conflict of interest statement
Financial disclosures/conflicts of interest: Bayer Pharmaceutical as Chair of Data Adjudication Committee, Femasys for reading ultrasounds in the study, and Consultant for Vesta startup for device development
Comment on
-
Benefits for cardiovascular system, bone density, and quality of life of a long-term hormone therapy in hysterectomized women: a 20-year follow-up study.Menopause. 2023 Oct 1;30(10):995-1001. doi: 10.1097/GME.0000000000002239. Epub 2023 Aug 23. Menopause. 2023. PMID: 37643383 Free PMC article.
References
-
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353–1368. doi: 10.1001/jama.2013.278040 - DOI
-
- Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016;374:1221–1231. doi: 10.1056/NEJMoa1505241 - DOI
-
- Miller VM, Naftolin F, Asthana S, et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause 2019;26:1071–1084. doi: 10.1097/GME.0000000000001326 - DOI
-
- Bhupathiraju SN, Grodstein F, Rosner BA, et al. Hormone therapy use and risk of chronic disease in the Nurses' Health Study: a comparative analysis with the Women's Health Initiative. Am J Epidemiol 2017;186:696–708. doi: 10.1093/aje/kwx131 - DOI
-
- Pourhadi N, Morch LS, Holm EA, et al. Menopausal hormone therapy and dementia: nationwide, nested case-control study. BMJ 2023;381:e072770. doi: 10.1136/bmj-2022-072770 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
